OurCrowd portfolio company MedAware was featured in Globes, the leading Israeli financial daily. Medication errors greatly affect a vast number of people and institutions, harming an estimated 1.5 million Americans each year. Medaware seeks to provide better preventative services than other prescription reviewing systems.
MedAware has developed an innovative software-based solution that combines the power of big data analytics and machine learning to save lives and reduce medical costs by combating prescription errors.
MedAware Co-Founder and CEO Gidi Stein said, “Three years ago I came across a tragic case of a nine-year-old Israeli boy who died because his primary-care physician accidentally prescribed the wrong drug. The ease with which a little boy died because of a mistaken click of a button was horrifying to me as a physician and as a parent. We have founded MedAware in order to try and prevent such cases.”
MedAware raised $1 million from GE Ventures and OurCrowd investors in 2014.
Read more on Globes here.